Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Adenocarcinoma"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1523
Tytuł:
Genetic Profiling of African American Patients With Prostatic Adenocarcinoma Metastatic to the Lymph Nodes: A Pilot Study.
Autorzy:
Bidot S; From the Departments of Pathology and Laboratory Medicine (Bidot, Zhang, Deeb, Smith, Hill, Tinsley, Harik).
Yin J; Department of Clinical and Translational Research, Caris Life Sciences, Phoenix, Arizona (Yin, Xiu).
Zhou P; Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, New York (Zhou).
Zhang L; From the Departments of Pathology and Laboratory Medicine (Bidot, Zhang, Deeb, Smith, Hill, Tinsley, Harik).
Deeb KK; From the Departments of Pathology and Laboratory Medicine (Bidot, Zhang, Deeb, Smith, Hill, Tinsley, Harik).
Smith G; From the Departments of Pathology and Laboratory Medicine (Bidot, Zhang, Deeb, Smith, Hill, Tinsley, Harik).
Hill CE; From the Departments of Pathology and Laboratory Medicine (Bidot, Zhang, Deeb, Smith, Hill, Tinsley, Harik).
Xiu J; Department of Clinical and Translational Research, Caris Life Sciences, Phoenix, Arizona (Yin, Xiu).
Bilen MA; Hematology and Oncology (Bilen, Carthon).; Winship Cancer Institute of Emory University, Atlanta, GA (Bilen, Harik).
Case KB; Emory University School of Medicine, Atlanta, Georgia (Case).
Tinsley M; From the Departments of Pathology and Laboratory Medicine (Bidot, Zhang, Deeb, Smith, Hill, Tinsley, Harik).
Carthon B; Hematology and Oncology (Bilen, Carthon).
Harik LR; From the Departments of Pathology and Laboratory Medicine (Bidot, Zhang, Deeb, Smith, Hill, Tinsley, Harik).; Winship Cancer Institute of Emory University, Atlanta, GA (Bilen, Harik).
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Mar 01; Vol. 148 (3), pp. 310-317.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Carrier Proteins*
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/pathology
Humans ; Male ; Androgen Antagonists ; Black or African American/genetics ; DNA Helicases ; Lymph Nodes/pathology ; Nuclear Proteins/genetics ; Pilot Projects ; Poly-ADP-Ribose Binding Proteins ; Receptors, Androgen/genetics ; Repressor Proteins/genetics ; Repressor Proteins/metabolism ; Retrospective Studies ; RNA Helicases/metabolism ; RNA Recognition Motif Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer.
Autorzy:
Salamini-Montemurri M; Centro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.; Facultade de Ciencias, Campus de A Zapateira, Universidade da Coruña, A Fraga, s/n, 15071 A Coruña, Spain.; Instituto de Investigación Biomédica de A Coruña (INIBIC), As Xubias de Arriba 84, 15006 A Coruña, Spain.
Vizoso-Vázquez Á; Centro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.; Facultade de Ciencias, Campus de A Zapateira, Universidade da Coruña, A Fraga, s/n, 15071 A Coruña, Spain.; Instituto de Investigación Biomédica de A Coruña (INIBIC), As Xubias de Arriba 84, 15006 A Coruña, Spain.
Barreiro-Alonso A; Centro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.; Facultade de Ciencias, Campus de A Zapateira, Universidade da Coruña, A Fraga, s/n, 15071 A Coruña, Spain.; Instituto de Investigación Biomédica de A Coruña (INIBIC), As Xubias de Arriba 84, 15006 A Coruña, Spain.
Lorenzo-Catoira L; Centro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.; Facultade de Ciencias, Campus de A Zapateira, Universidade da Coruña, A Fraga, s/n, 15071 A Coruña, Spain.; Instituto de Investigación Biomédica de A Coruña (INIBIC), As Xubias de Arriba 84, 15006 A Coruña, Spain.
Rodríguez-Belmonte E; Centro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.; Facultade de Ciencias, Campus de A Zapateira, Universidade da Coruña, A Fraga, s/n, 15071 A Coruña, Spain.; Instituto de Investigación Biomédica de A Coruña (INIBIC), As Xubias de Arriba 84, 15006 A Coruña, Spain.
Cerdán ME; Centro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.; Facultade de Ciencias, Campus de A Zapateira, Universidade da Coruña, A Fraga, s/n, 15071 A Coruña, Spain.; Instituto de Investigación Biomédica de A Coruña (INIBIC), As Xubias de Arriba 84, 15006 A Coruña, Spain.
Lamas-Maceiras M; Centro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.; Facultade de Ciencias, Campus de A Zapateira, Universidade da Coruña, A Fraga, s/n, 15071 A Coruña, Spain.; Instituto de Investigación Biomédica de A Coruña (INIBIC), As Xubias de Arriba 84, 15006 A Coruña, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 07; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
HMGB1 Protein*/genetics
HMGB1 Protein*/metabolism
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/pathology
Humans ; Male ; Cell Line ; HMGB2 Protein/genetics ; HMGB2 Protein/metabolism ; Transcription Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities.
Autorzy:
Viehweger F; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Böcker C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Weidemann S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Freytag M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Menz A; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Büscheck F; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Luebke AM; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Putri D; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Kluth M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Hube-Magg C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Hinsch A; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Lennartz M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Lutz F; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Reiswich V; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Höflmayer D; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Fraune C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Möller K; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Bernreuther C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Lebok P; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.; Institute of Pathology, Clinical Center Osnabrueck, Am Finkenhuegel 1, Osnabrueck, 49076, Germany.
Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Steurer S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Dum D; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Marx AH; Department of Pathology, Academic Hospital Fuerth, Jakob-Henle-Straße 1, Fuerth, 90766, Germany.
Simon R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. .
Krech T; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.; Institute of Pathology, Clinical Center Osnabrueck, Am Finkenhuegel 1, Osnabrueck, 49076, Germany.
Clauditz TS; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Jacobsen F; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Gorbokon N; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Burandt E; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Minner S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Kind S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2024 Jan 13; Vol. 19 (1), pp. 12. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/pathology
Adenocarcinoma*/pathology
Male ; Humans ; Membrane Proteins ; Immunohistochemistry ; Biomarkers, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic value of mitochondrial CKMT2 in Pan-cancer and its tumor immune correlation analysis.
Autorzy:
Lin W; State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Zhou J; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China.
Ma Y; Department of Pathology, Affiliated Cancer Hospital of Guangxi Medical University, Nanning, China.
Ge L; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China.
Luo Y; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China.
Wang Y; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China.
Zhou S; State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, 530021, Guangxi, China. .; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 03; Vol. 14 (1), pp. 342. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*
Adenocarcinoma of Lung*
Colonic Neoplasms*
Lung Neoplasms*
Male ; Humans ; Prognosis ; Carcinogenesis ; Tumor Microenvironment/genetics ; Creatine Kinase, Mitochondrial Form
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Utilization of NKX3.1, P501S, Prostate-Specific Antigen, and Steroidogenic Factor 1 to Distinguish Malignant Leydig Cell Tumor From Metastatic Prostatic Adenocarcinoma to the Testis.
Autorzy:
Erak E; From the Department of Pathology (Erak, Epstein), The Johns Hopkins Hospital, Baltimore, Maryland.
Ulbright TM; The Department of Pathology, Indiana University School of Medicine, Indianapolis (Ulbright).
Epstein J; From the Department of Pathology (Erak, Epstein), The Johns Hopkins Hospital, Baltimore, Maryland.; The Department of Urology (Epstein), The Johns Hopkins Hospital, Baltimore, Maryland.; The Department of Oncology (Epstein), Johns Hopkins Hospital, Baltimore, Maryland.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2023 Dec 01; Vol. 147 (12), pp. 1458-1460.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Leydig Cell Tumor*/diagnosis
Prostatic Neoplasms*/pathology
Testicular Neoplasms*/secondary
Humans ; Male ; Biomarkers, Tumor ; Prostate-Specific Antigen ; Steroidogenic Factor 1 ; Transcription Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Pathology Data-Based Risk Group Stratification Is Equivalent to That Obtained by Oncotype DX Testing in Prostatic Adenocarcinoma.
Autorzy:
Renavikar PS; From the Department of Pathology and Microbiology (Renavikar, Lele), University of Nebraska Medical Center, Omaha, Nebraska.
LaGrange CA; The Division of Urologic Surgery in the Department of Surgery (LaGrange), University of Nebraska Medical Center, Omaha, Nebraska.
Lele SM; From the Department of Pathology and Microbiology (Renavikar, Lele), University of Nebraska Medical Center, Omaha, Nebraska.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2023 Oct 01; Vol. 147 (10), pp. 1158-1163.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/pathology
Carcinoma*
Adenocarcinoma*/diagnosis
Adenocarcinoma*/genetics
Male ; Humans ; Prostate-Specific Antigen ; Risk Factors ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Artifactual Cystic Spaces in Prostatic Transurethral Resections and Related Specimens: A Potential Diagnostic Confounder.
Autorzy:
Sangoi AR; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, El Camino Hospital, Mountain View, CA, USA.
Akgul M; Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY, USA.
Williamson SR; Department of Pathology, Cleveland Clinic, Cleveland, OH, USA.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Sep; Vol. 31 (6), pp. 1048-1056. Date of Electronic Publication: 2022 Oct 30.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/surgery
Adenocarcinoma*/diagnosis
Adenocarcinoma*/surgery
Adenocarcinoma*/pathology
Urinary Bladder Neoplasms*/surgery
Transurethral Resection of Prostate*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Rare Case of Co-Existing Mucin-Producing Urothelial-Type Adenocarcinoma of the Prostate and Acinar Adenocarcinoma.
Autorzy:
Nova-Camacho LM; Department of Pathology, Hospital Universitario Donostia, San Sebastian, Spain.
Villafruela Mateos A; Department of Urology, Hospital Universitario Donostia, San Sebastian, Spain.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Aug; Vol. 31 (5), pp. 627-633. Date of Electronic Publication: 2022 Jul 29.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma, Mucinous*/pathology
Prostatic Neoplasms*/pathology
Carcinoma, Acinar Cell*
Male ; Humans ; Aged ; Prostate/pathology ; Mucins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.
Autorzy:
Nyati S; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.; Department of Radiology, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, United States of America.
Stricker H; Vattikuti Urology Institute, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
Barton KN; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
Li P; Department of Public Health Sciences, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
Elshaikh M; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
Ali H; Department of Internal Medicine, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
Brown SL; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.; College of Human Medicine, Michigan State University, East Lansing, Michigan, United States of America.
Hwang C; Department of Internal Medicine, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
Peabody J; Vattikuti Urology Institute, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
Freytag SO; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
Movsas B; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.; College of Human Medicine, Michigan State University, East Lansing, Michigan, United States of America.
Siddiqui F; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Sep 15; Vol. 18 (9), pp. e0291315. Date of Electronic Publication: 2023 Sep 15 (Print Publication: 2023).
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Adenocarcinoma*/therapy
Prostatic Neoplasms*/therapy
Oncolytic Virotherapy*
Humans ; Male ; Adenoviridae ; Genetic Therapy/adverse effects ; Interleukin-12/genetics ; Leukocytes, Mononuclear ; Prostate ; Genes, Transgenic, Suicide
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High-Grade Desmoplastic Foamy Gland Prostatic Adenocarcinoma.
Autorzy:
Gao G; From the Department of Pathology (Gao, Epstein), The Johns Hopkins Hospital, Baltimore, Maryland.
Epstein JI; From the Department of Pathology (Gao, Epstein), The Johns Hopkins Hospital, Baltimore, Maryland.; From the Department of Urology (Epstein), The Johns Hopkins Hospital, Baltimore, Maryland.; From the Department of Oncology (Epstein), The Johns Hopkins Hospital, Baltimore, Maryland.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2023 Sep 01; Vol. 147 (9), pp. 1039-1049.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/pathology
Adenocarcinoma*/pathology
Male ; Humans ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Prostate/surgery ; Prostate/pathology ; Prostatectomy ; Biopsy, Needle
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Outlook of Gleason score in prostate carcinoma and correlation with PSA levels: A study in a tertiary care hospital.
Autorzy:
Rani E; Department of Pathology, GGS Medical College -Faridkot, Punjab, India.
Nibhoria S; Department of Pathology, GGS Medical College -Faridkot, Punjab, India.
Nagpal N; Department of Surgery, GGS Medical College -Faridkot, Punjab, India.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jul-Sep; Vol. 19 (5), pp. 1305-1310.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/pathology
Carcinoma*/pathology
Adenocarcinoma*/pathology
Male ; Humans ; Prostate-Specific Antigen ; Prostate/pathology ; Neoplasm Grading ; Tertiary Care Centers ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Discriminant Efficacy of mpMRI for Variant Pathology Associated with Prostate Adenocarcinoma.
Autorzy:
Köseoğlu H; o Health Sciences University, Hamidiye Faculty of Medicine, Istanbul Health Practice and Research Center, Department of Urology, Istanbul, Turkey. .
Çevik Cenkeri H; o Okan University, Faculty of Medicine, Department of Radiology, Turkey. .
Eroğlu T; o Semdinli State Hospital, Department of Urology, Hakkari, Turkey. .
Yalçın B; o Health Sciences University, Hamidiye Faculty of Medicine, Istanbul Health Practice and Research Center, Department of Radiation Oncology, Istanbul, Turkey. .
Pokaż więcej
Źródło:
Urology journal [Urol J] 2023 May 21; Vol. 20 (3), pp. 157-161. Date of Electronic Publication: 2023 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Multiparametric Magnetic Resonance Imaging*/methods
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/surgery
Adenocarcinoma*/pathology
Male ; Humans ; Prostate/pathology ; Retrospective Studies ; Magnetic Resonance Imaging/methods ; Prostatectomy/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Analysis of survival and prognostic factors of clear cell adenocarcinoma of the prostate: a case-control study for a rare cancer entity.
Autorzy:
Chen S; Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410005, Hunan Province, China.
Song W; Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410005, Hunan Province, China.
Zhang R; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.; Department of Urology, Fujian Provincial Hospital, Fuzhou, China.
Jin Y; Department of Urology, Juntendo University School of Medicine, Tokyo, Japan.
Lu Y; Department of Urology, Juntendo University School of Medicine, Tokyo, Japan.
Lin L; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.; Department of Urology, Fujian Provincial Hospital, Fuzhou, China.
Ye L; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.; Department of Urology, Fujian Provincial Hospital, Fuzhou, China.
Li T; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China. .; Department of Urology, Fujian Provincial Hospital, Fuzhou, China. .
Wei Y; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China. .; Department of Urology, Fujian Provincial Hospital, Fuzhou, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 26; Vol. 13 (1), pp. 10317. Date of Electronic Publication: 2023 Jun 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma, Clear Cell*
Carcinoma, Acinar Cell*
Prostatic Neoplasms*/pathology
Male ; Humans ; Aged ; Case-Control Studies ; Prostate/pathology ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prostate Cancer Metastasis to Stomach: A Case Report and Review of Literature.
Autorzy:
Moshref L; Department of Surgery, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Abidullah M; Department of Pathology, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.
Czaykowski P; Section of Hematology/Oncology, Department of Internal Medicine, University of Manitoba and CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Chowdhury A; Department of Radiation Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Wightman R; Department of Pathology, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.
Hebbard P; Department of Surgery, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.; Department of Surgical Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Mar 30; Vol. 30 (4), pp. 3901-3914. Date of Electronic Publication: 2023 Mar 30.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Prostatic Neoplasms*/pathology
Adenocarcinoma*/diagnosis
Adenocarcinoma*/pathology
Stomach Neoplasms*
Male ; Humans ; Aged ; Gastroscopy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis.
Autorzy:
Lin Y; Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Zhang Y; Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Tuo Z; Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Gao L; Center for Clinical Medicine, Huatuo Institute of Medical Innovation (HTIMI), Berlin, Germany.
Ding D; Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Bi L; Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Yu D; Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Lv Z; Department of Histology and Embryology, School of Basic Medical Sciences, Anhui Medical University, Anhui, China.
Wang J; School of Health Administration, Anhui Medical University, Hefei, China.; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.; Berlin Institute of Health, Institute for Social Medicine, Epidemiology and Health Economics, Berlin, Germany.
Chen X; Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Mar 29; Vol. 23 (1), pp. 285. Date of Electronic Publication: 2023 Mar 29.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/genetics
Adenocarcinoma*/genetics
Male ; Humans ; Prognosis ; Prostate ; Biomarkers ; Tumor Microenvironment ; Origin Recognition Complex
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stress-Inducible SCAND Factors Suppress the Stress Response and Are Biomarkers for Enhanced Prognosis in Cancers.
Autorzy:
Sheta M; Department of Dental Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.; Department of Cancer Biology, National Cancer Institute, Cairo University, Cairo 11796, Egypt.
Yoshida K; Department of Dental Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.; Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.
Kanemoto H; Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.
Calderwood SK; Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Eguchi T; Department of Dental Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 08; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*
Prostatic Neoplasms*
Male ; Humans ; Cell Line, Tumor ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Heat-Shock Proteins/genetics ; Heat-Shock Proteins/metabolism ; HSP90 Heat-Shock Proteins/metabolism ; RNA ; Biomarkers ; Heat Shock Transcription Factors/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cytological findings of metastatic poorly differentiated prostate adenocarcinoma to Virchow's node with immunohistochemical positivity for CD10 and negativity for PSA.
Autorzy:
Kobayashi G; Department of Pathology, Kure-Kyosai Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Hiroshima, Japan.
Sentani K; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Uraoka N; Department of Pathology, Kure-Kyosai Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Hiroshima, Japan.
Oue N; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Sasaki N; Department of Pathology, Kure-Kyosai Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Hiroshima, Japan.
Pokaż więcej
Źródło:
Cytopathology : official journal of the British Society for Clinical Cytology [Cytopathology] 2022 Nov; Vol. 33 (6), pp. 749-753. Date of Electronic Publication: 2022 May 26.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/diagnosis
Adenocarcinoma*/pathology
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/pathology
Humans ; Lymphatic Metastasis ; Male ; Prostate/pathology ; Prostate-Specific Antigen
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma.
Autorzy:
Hu QY; Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou 318000, China.; Department of Pharmacy, Hebei Key Laboratory of Neuropharmacology, Hebei North University, Zhangjiakou 075000, China.
Liu J; School of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Zhang XK; School of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Yang WT; School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230038, China.
Tao YT; Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou 318000, China.
Chen C; Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou 318000, China.; Department of Pharmacy, Hebei Key Laboratory of Neuropharmacology, Hebei North University, Zhangjiakou 075000, China.
Qian YH; Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou 318000, China.
Tang JS; Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Yao XS; Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Xu YH; Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou 318000, China.
Wang JH; School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230038, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Jan 28; Vol. 28 (3). Date of Electronic Publication: 2023 Jan 28.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/drug therapy
Adenocarcinoma*/genetics
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/genetics
Nuclear Receptor Subfamily 4, Group A, Member 1*/genetics
Humans ; Male ; Biomarkers ; Prognosis ; Prostate ; Tumor Microenvironment/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inference of core needle biopsy whole slide images requiring definitive therapy for prostate cancer.
Autorzy:
Tsuneki M; Medmain Research, Medmain Inc., 2-4-5-104, Akasaka, Chuo-ku, Fukuoka, 810-0042, Japan. .
Abe M; Department of Pathology, Tochigi Cancer Center, 4-9-13 Yohnan, Utsunomiya, 320-0834, Japan.
Ichihara S; Department of Surgical Pathology, Sapporo Kosei General Hospital, 8-5 Kita-3-jo Higashi, Chuo-ku, Sapporo, 060-0033, Japan.
Kanavati F; Medmain Research, Medmain Inc., 2-4-5-104, Akasaka, Chuo-ku, Fukuoka, 810-0042, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jan 05; Vol. 23 (1), pp. 11. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/therapy
Prostatic Neoplasms*/pathology
Adenocarcinoma*/diagnosis
Adenocarcinoma*/therapy
Male ; Humans ; Biopsy, Large-Core Needle ; Reproducibility of Results ; Ontario
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cribriform Pattern of The Prostate Adenocarcinoma: Sensitivity of Multiparametric MRI.
Autorzy:
Tuna MB; Department of Urology, Acibadem Maslak Hospital, Istanbul, Turkey. .
Arslan A; Department of Radiology, Umraniye Training and Research Hospital; Istanbul,Turkey.
Kök YB; Department of Pathology, Acibadem Mehmet Ali Aydinlar University Medical Faculty, Istanbul, Turkey.
Doganca T; Department of Urology, Acibadem Taksim Hospital, Istanbul, Turkey.
Argun OB; Department of Urology, Acibadem Mehmet Ali Aydinlar University Medical Faculty, Istanbul, Turkey.
Tufek I; Department of Urology, Acibadem Mehmet Ali Aydinlar University Medical Faculty, Istanbul, Turkey.
Pirdal BZ; Department of Public Health, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Kocamustafapasa, Fatih, 34098 Istanbul, Turkey.
Saglican Y; Department of Pathology, Acibadem Mehmet Ali Aydinlar University Medical Faculty, Istanbul, Turkey.
Obek C; Department of Urology, Acibadem Mehmet Ali Aydinlar University Medical Faculty, Istanbul, Turkey.
Karaarslan E; Department of Radiology, Acibadem Mehmet Ali Aydinlar University Medical Faculty, Istanbul, Turkey.
Kural AR; Department of Urology, Acibadem Mehmet Ali Aydinlar University Medical Faculty, Istanbul, Turkey.
Pokaż więcej
Źródło:
Urology journal [Urol J] 2022 Dec 25; Vol. 20 (1), pp. 34-40. Date of Electronic Publication: 2022 Dec 25.
Typ publikacji:
Journal Article
MeSH Terms:
Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms*/pathology
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/pathology
Male ; Humans ; Prostate/diagnostic imaging ; Prostate/pathology ; Retrospective Studies ; Magnetic Resonance Imaging ; Prostatectomy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 1523

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies